Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Additional Valerian Safety Data Needed To Gain OTC Status, FDA Says

This article was originally published in The Tan Sheet

Executive Summary

Additional data on valerian's safety must be provided to FDA before the agency can consider including the botanical in the final monograph for OTC nighttime sleep aid drugs, FDA states in an April 7 letter to European-American Phytomedicines Coalition (EAPC) counsel Robert Pinco
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS095409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel